Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      Homeprconnect

      prconnect

      Hillstream BioPharma Provides Corporate Update
      Health

      Hillstream BioPharma Provides Corporate Update

      June 2, 2022
      Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
      Health

      Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      June 2, 2022
      Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon in the United States
      Health

      Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon in the United States

      June 2, 2022
      Guardion Health Sciences Announces Agreement with OmegaQuant Laboratories
      Health

      Guardion Health Sciences Announces Agreement with OmegaQuant Laboratories

      June 1, 2022
      Compugen to Present at Upcoming Investor Conferences
      Health

      Compugen to Present at Upcoming Investor Conferences

      June 1, 2022
      Outlook Therapeutics Provides Update on Biologics License Application (BLA) Submission for ONS-5010 as a Treatment for Wet AMD
      Health

      Outlook Therapeutics Provides Update on Biologics License Application (BLA) Submission for ONS-5010 as a Treatment for Wet AMD

      May 31, 2022
      Biora Therapeutics Shares Presentation of Patient Data Establishing Correlation Between Drug Levels in Colon and Patient Outcomes in Ulcerative Colitis
      Health

      Biora Therapeutics Shares Presentation of Patient Data Establishing Correlation Between Drug Levels in Colon and Patient Outcomes in Ulcerative Colitis

      May 31, 2022
      « 1 … 356 357 358

       

      LATEST NEWS

      • Investing News Oracle’s Q3 Earnings Surge in 2026
      • Investing News Rheinmetall’s Strong 2025 Earnings Boost
      • Investing News Lego’s 2025 Earnings Boost Toy Industry
      • Investing News Volkswagen 2025 Earnings Revealed
      • Investing News Oracle’s AI and Data Center Expansion

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026